PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Wenjing Wang

Zhejiang Cancer Hospital

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · JOURNAL ARTICLE

Chemotherapy remains effective in ALK-TKI therapy: a retrospective analysis in ALK-positive advanced NSCLC

BMC Cancer

Retrospective analysis of 109 patients showing statistically significant survival benefits with chemotherapy integration in ALK-positive NSCLC, but limited by observational design, potential confounding, and lack of randomization.

PromisingWenjing Wang Lung Cancer Research Studies Lung Cancer Treatments and Mutations

Reported

Sample size109

Median PFS2 (chemotherapy vs. no…29.9 vs. 23.4 months

P-value (PFS2 with vs. without ch…0.039

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support